Mar 18, 2020
Pharmascience Inc. launches pms-FLUTICASONE PROPIONATE/SALMETEROL DPI for the maintenance treatment of asthma and COPD
Nov 16, 2019
Pharmascience Inc. contributes to the Montreal Heart Institute's COLchicine Cardiovascular Outcome Trial (COLCOT), a landmark study to benefit cardiovascular patients and the healthcare system
Oct 31, 2019
Pharmascience Inc. launches pms-FINGOLIMOD for the treatment of relapsing-remitting multiple sclerosis (MS) in adults
Oct 30, 2019
Information Update - Ranbaxy Pharmaceuticals Canada Inc. recalls prescription ranitidine products as a precaution; request to stop distribution remains in place while Health Canada continues to assess NDMA
May 10, 2019
Pharmascience Inc. launches Royalmount Laboratories, a new analytical service division in Montreal
Apr 03, 2019
Pivot Pharma Signs Letter of Intent with Pharmascience Inc.
Mar 29, 2019
Pharmascience Inc. launches (Pr)pms-PROGESTERONE 200 mg capsule indicated as an adjunct to postmenopausal estrogen replacement therapy
Mar 28, 2019
Pharmascience Delivers Life-saving Drugs with Real-time Document Management from OpenText
Nov 20, 2018
Oculis Strengthens its Global Clinical and Business Development Capabilities Through Strategic Appointments to Senior Management Team
Jul 04, 2018
Pharmascience Inc. launches (Pr)pms-TRANDOLAPRIL, first generic bioequivalent to (Pr)MAVIK® available on the market, for the treatment of mild to moderate essential hypertension
May 30, 2018
PharmaBoardroom Releases 'Healthcare and Life Sciences Review Canada' May 2018 Pharma Report
May 14, 2018
Pharmascience Inc. Launches (Pr)pms-NITROFURANTOIN, First Generic Bioequivalent to MacroBID® Available on the Market, for the Treatment of Urinary Tract Infections
Apr 09, 2018
Peter Hardwick of Apotex Elected Chair of Canadian Generic Pharmaceutical Association
Nov 16, 2017
RDD Pharma Raises $9.5M in Series B Funding to Fuel Global Development
Sep 20, 2017
Pendopharm, a division of Pharmascience Inc., Invests in Ontario based Edesa Biotech and Licenses Three Novel Anorectal Treatments for Canada
Sep 20, 2017
Edesa Biotech Completes Financing to Develop Novel Dermatology and Anorectal Treatments